Wijziging van de Wet geneesmiddelenprijzen in verband met een aanpassing van de referentielanden

This procedure proposes to amend the Dutch Medicine Prices Act by updating the list of reference countries used to determine the maximum prices of medicines. This ensures that pharmaceutical pricing remains aligned with international benchmarks and current market standards. This change primarily affects pharmaceutical companies and healthcare payers in the Netherlands by adjusting how the government calculates the ceiling prices for medicinal products.